PHARM
Kimberly Novak, PharmD, BCPS, BCPPS, FPPA
Dept. of Pharmacy
Nationwide Children's Hospital
Sabrina Sherwood, PharmD
Pharmacy
St. Luke's Cystic Fibrosis Center of Idaho
This session will focus on CF pharmacotherapy issues facing practitioners today. The topics that will be discussed are clinical outcomes of real world CFTR modulator use in the CF population, medication toxicities, and models of pharmacy integration within the CF care team. This session will review the changing landscape in clinical care of patients taking CFTR modulators. Topics selected for this session are pertinent to today's CF pharmacy team's practice as clinical care continues to evolve.
Speaker: Justin Moss, CPhT – Intermountain Primary Children's Hospital
Speaker: Jasmine R. Pare, PharmD – University of California, San Francisco
Speaker: Rebecca S. Pettit, PharmD, MBA, BCPS, BCPPS, FCCP – Riley Hospital for Children at IU Health
Speaker: Jennifer S. Guimbellot, M.D. – University of Alabama at Birmingham
Speaker: Yaling Yi, MS – University of Iowa